Reconfiguration of a Latecomer Innovation System: Governing Pharmaceutical Biotechnology Innovation in South Korea
The book examines the evolving governance of pharmaceutical biotechnology in South Korea in order to derive conclusions about the dynamics of a latecomer system transition. Based on an analysis of innovation activities in the biomedical sector, which is complemented by expert interviews, the researc...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Frankfurt am Main
Peter Lang GmbH, Internationaler Verlag der Wissenschaften
2014
|
| Schriftenreihe: | Emerging Markets Studies
v.4 |
| Schlagworte: | |
| Zusammenfassung: | The book examines the evolving governance of pharmaceutical biotechnology in South Korea in order to derive conclusions about the dynamics of a latecomer system transition. Based on an analysis of innovation activities in the biomedical sector, which is complemented by expert interviews, the research contends that the Korean post-developmental state should be geared towards coordinating the interplay of technologies, modes of organization and institutions. An integrative framework is developed to describe system change as a co-evolutionary process in which the national and sectoral dimensions intersect. The case shows that the shaping of an environment in which innovation systems can develop sectoral transformative capacity is a central aspect of latecomer innovation governance |
| Beschreibung: | Description based on publisher supplied metadata and other sources |
| Beschreibung: | 1 online resource (304 pages) |
| ISBN: | 9783653033267 9783631643341 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV043611130 | ||
| 003 | DE-604 | ||
| 005 | 20180322 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160616s2014 |||| o||u| ||||||eng d | ||
| 020 | |a 9783653033267 |9 978-3-653-03326-7 | ||
| 020 | |a 9783631643341 |c Print |9 978-3-631-64334-1 | ||
| 035 | |a (ZDB-30-PQE)EBC1752961 | ||
| 035 | |a (ZDB-89-EBL)EBL1752961 | ||
| 035 | |a (ZDB-38-EBR)ebr10891677 | ||
| 035 | |a (OCoLC)889250219 | ||
| 035 | |a (DE-599)BVBBV043611130 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 338.4/76151095195 | |
| 100 | 1 | |a Johann, Dirk |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Reconfiguration of a Latecomer Innovation System |b Governing Pharmaceutical Biotechnology Innovation in South Korea |
| 264 | 1 | |a Frankfurt am Main |b Peter Lang GmbH, Internationaler Verlag der Wissenschaften |c 2014 | |
| 264 | 4 | |c © 2014 | |
| 300 | |a 1 online resource (304 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Emerging Markets Studies |v v.4 | |
| 500 | |a Description based on publisher supplied metadata and other sources | ||
| 520 | |a The book examines the evolving governance of pharmaceutical biotechnology in South Korea in order to derive conclusions about the dynamics of a latecomer system transition. Based on an analysis of innovation activities in the biomedical sector, which is complemented by expert interviews, the research contends that the Korean post-developmental state should be geared towards coordinating the interplay of technologies, modes of organization and institutions. An integrative framework is developed to describe system change as a co-evolutionary process in which the national and sectoral dimensions intersect. The case shows that the shaping of an environment in which innovation systems can develop sectoral transformative capacity is a central aspect of latecomer innovation governance | ||
| 650 | 4 | |a Biotechnology industries -- Technological innovations -- Korea (South) | |
| 650 | 4 | |a Industrial policy -- Korea (South) | |
| 650 | 4 | |a Pharmaceutical biotechnology -- Technological innovations -- Korea (South) | |
| 650 | 4 | |a Pharmaceutical biotechnology industry -- Technological innovations -- Korea (South) | |
| 650 | 4 | |a Pharmaceutical industry -- Technological innovations -- Korea (South) | |
| 650 | 0 | 7 | |a Biotechnologie |0 (DE-588)4069491-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wirtschaftssektor |0 (DE-588)4191554-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Innovation |0 (DE-588)4027089-0 |2 gnd |9 rswk-swf |
| 651 | 7 | |a Südkorea |0 (DE-588)4078029-6 |2 gnd |9 rswk-swf | |
| 655 | 7 | |8 1\p |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Südkorea |0 (DE-588)4078029-6 |D g |
| 689 | 0 | 1 | |a Biotechnologie |0 (DE-588)4069491-4 |D s |
| 689 | 0 | 2 | |a Wirtschaftssektor |0 (DE-588)4191554-9 |D s |
| 689 | 0 | 3 | |a Innovation |0 (DE-588)4027089-0 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Johann, Dirk |t Reconfiguration of a Latecomer Innovation System : Governing Pharmaceutical Biotechnology Innovation in South Korea |
| 912 | |a ZDB-30-PQE | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029025189 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804176356188094464 |
|---|---|
| any_adam_object | |
| author | Johann, Dirk |
| author_facet | Johann, Dirk |
| author_role | aut |
| author_sort | Johann, Dirk |
| author_variant | d j dj |
| building | Verbundindex |
| bvnumber | BV043611130 |
| collection | ZDB-30-PQE |
| ctrlnum | (ZDB-30-PQE)EBC1752961 (ZDB-89-EBL)EBL1752961 (ZDB-38-EBR)ebr10891677 (OCoLC)889250219 (DE-599)BVBBV043611130 |
| dewey-full | 338.4/76151095195 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/76151095195 |
| dewey-search | 338.4/76151095195 |
| dewey-sort | 3338.4 1176151095195 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03338nmm a2200577zcb4500</leader><controlfield tag="001">BV043611130</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180322 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160616s2014 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783653033267</subfield><subfield code="9">978-3-653-03326-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783631643341</subfield><subfield code="c">Print</subfield><subfield code="9">978-3-631-64334-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PQE)EBC1752961</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL1752961</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-38-EBR)ebr10891677</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)889250219</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043611130</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/76151095195</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Johann, Dirk</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Reconfiguration of a Latecomer Innovation System</subfield><subfield code="b">Governing Pharmaceutical Biotechnology Innovation in South Korea</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Frankfurt am Main</subfield><subfield code="b">Peter Lang GmbH, Internationaler Verlag der Wissenschaften</subfield><subfield code="c">2014</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (304 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Emerging Markets Studies</subfield><subfield code="v">v.4</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The book examines the evolving governance of pharmaceutical biotechnology in South Korea in order to derive conclusions about the dynamics of a latecomer system transition. Based on an analysis of innovation activities in the biomedical sector, which is complemented by expert interviews, the research contends that the Korean post-developmental state should be geared towards coordinating the interplay of technologies, modes of organization and institutions. An integrative framework is developed to describe system change as a co-evolutionary process in which the national and sectoral dimensions intersect. The case shows that the shaping of an environment in which innovation systems can develop sectoral transformative capacity is a central aspect of latecomer innovation governance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology industries -- Technological innovations -- Korea (South)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrial policy -- Korea (South)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology -- Technological innovations -- Korea (South)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology industry -- Technological innovations -- Korea (South)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry -- Technological innovations -- Korea (South)</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirtschaftssektor</subfield><subfield code="0">(DE-588)4191554-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Innovation</subfield><subfield code="0">(DE-588)4027089-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Südkorea</subfield><subfield code="0">(DE-588)4078029-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Südkorea</subfield><subfield code="0">(DE-588)4078029-6</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Wirtschaftssektor</subfield><subfield code="0">(DE-588)4191554-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Innovation</subfield><subfield code="0">(DE-588)4027089-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Johann, Dirk</subfield><subfield code="t">Reconfiguration of a Latecomer Innovation System : Governing Pharmaceutical Biotechnology Innovation in South Korea</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PQE</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029025189</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| geographic | Südkorea (DE-588)4078029-6 gnd |
| geographic_facet | Südkorea |
| id | DE-604.BV043611130 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:30:53Z |
| institution | BVB |
| isbn | 9783653033267 9783631643341 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029025189 |
| oclc_num | 889250219 |
| open_access_boolean | |
| physical | 1 online resource (304 pages) |
| psigel | ZDB-30-PQE |
| publishDate | 2014 |
| publishDateSearch | 2014 |
| publishDateSort | 2014 |
| publisher | Peter Lang GmbH, Internationaler Verlag der Wissenschaften |
| record_format | marc |
| series2 | Emerging Markets Studies |
| spelling | Johann, Dirk Verfasser aut Reconfiguration of a Latecomer Innovation System Governing Pharmaceutical Biotechnology Innovation in South Korea Frankfurt am Main Peter Lang GmbH, Internationaler Verlag der Wissenschaften 2014 © 2014 1 online resource (304 pages) txt rdacontent c rdamedia cr rdacarrier Emerging Markets Studies v.4 Description based on publisher supplied metadata and other sources The book examines the evolving governance of pharmaceutical biotechnology in South Korea in order to derive conclusions about the dynamics of a latecomer system transition. Based on an analysis of innovation activities in the biomedical sector, which is complemented by expert interviews, the research contends that the Korean post-developmental state should be geared towards coordinating the interplay of technologies, modes of organization and institutions. An integrative framework is developed to describe system change as a co-evolutionary process in which the national and sectoral dimensions intersect. The case shows that the shaping of an environment in which innovation systems can develop sectoral transformative capacity is a central aspect of latecomer innovation governance Biotechnology industries -- Technological innovations -- Korea (South) Industrial policy -- Korea (South) Pharmaceutical biotechnology -- Technological innovations -- Korea (South) Pharmaceutical biotechnology industry -- Technological innovations -- Korea (South) Pharmaceutical industry -- Technological innovations -- Korea (South) Biotechnologie (DE-588)4069491-4 gnd rswk-swf Wirtschaftssektor (DE-588)4191554-9 gnd rswk-swf Innovation (DE-588)4027089-0 gnd rswk-swf Südkorea (DE-588)4078029-6 gnd rswk-swf 1\p (DE-588)4113937-9 Hochschulschrift gnd-content Südkorea (DE-588)4078029-6 g Biotechnologie (DE-588)4069491-4 s Wirtschaftssektor (DE-588)4191554-9 s Innovation (DE-588)4027089-0 s 2\p DE-604 Erscheint auch als Druck-Ausgabe Johann, Dirk Reconfiguration of a Latecomer Innovation System : Governing Pharmaceutical Biotechnology Innovation in South Korea 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Johann, Dirk Reconfiguration of a Latecomer Innovation System Governing Pharmaceutical Biotechnology Innovation in South Korea Biotechnology industries -- Technological innovations -- Korea (South) Industrial policy -- Korea (South) Pharmaceutical biotechnology -- Technological innovations -- Korea (South) Pharmaceutical biotechnology industry -- Technological innovations -- Korea (South) Pharmaceutical industry -- Technological innovations -- Korea (South) Biotechnologie (DE-588)4069491-4 gnd Wirtschaftssektor (DE-588)4191554-9 gnd Innovation (DE-588)4027089-0 gnd |
| subject_GND | (DE-588)4069491-4 (DE-588)4191554-9 (DE-588)4027089-0 (DE-588)4078029-6 (DE-588)4113937-9 |
| title | Reconfiguration of a Latecomer Innovation System Governing Pharmaceutical Biotechnology Innovation in South Korea |
| title_auth | Reconfiguration of a Latecomer Innovation System Governing Pharmaceutical Biotechnology Innovation in South Korea |
| title_exact_search | Reconfiguration of a Latecomer Innovation System Governing Pharmaceutical Biotechnology Innovation in South Korea |
| title_full | Reconfiguration of a Latecomer Innovation System Governing Pharmaceutical Biotechnology Innovation in South Korea |
| title_fullStr | Reconfiguration of a Latecomer Innovation System Governing Pharmaceutical Biotechnology Innovation in South Korea |
| title_full_unstemmed | Reconfiguration of a Latecomer Innovation System Governing Pharmaceutical Biotechnology Innovation in South Korea |
| title_short | Reconfiguration of a Latecomer Innovation System |
| title_sort | reconfiguration of a latecomer innovation system governing pharmaceutical biotechnology innovation in south korea |
| title_sub | Governing Pharmaceutical Biotechnology Innovation in South Korea |
| topic | Biotechnology industries -- Technological innovations -- Korea (South) Industrial policy -- Korea (South) Pharmaceutical biotechnology -- Technological innovations -- Korea (South) Pharmaceutical biotechnology industry -- Technological innovations -- Korea (South) Pharmaceutical industry -- Technological innovations -- Korea (South) Biotechnologie (DE-588)4069491-4 gnd Wirtschaftssektor (DE-588)4191554-9 gnd Innovation (DE-588)4027089-0 gnd |
| topic_facet | Biotechnology industries -- Technological innovations -- Korea (South) Industrial policy -- Korea (South) Pharmaceutical biotechnology -- Technological innovations -- Korea (South) Pharmaceutical biotechnology industry -- Technological innovations -- Korea (South) Pharmaceutical industry -- Technological innovations -- Korea (South) Biotechnologie Wirtschaftssektor Innovation Südkorea Hochschulschrift |
| work_keys_str_mv | AT johanndirk reconfigurationofalatecomerinnovationsystemgoverningpharmaceuticalbiotechnologyinnovationinsouthkorea |